U.S. Luxury Stock News

NYSE:Q
NYSE:QSemiconductor

A Look At Qnity Electronics (Q) Valuation After Earnings Beat And New Buyback Plan

Why Qnity Electronics (Q) Is Back on Investors’ Radar Qnity Electronics (Q) has drawn fresh attention after reporting Q4 2025 results that topped analyst revenue and earnings expectations, rolling out a multi year productivity plan, and approving a US$500 million share repurchase program. See our latest analysis for Qnity Electronics. The strong Q4 surprise, fresh 2026 net sales guidance and new M&A ambitions have coincided with powerful momentum, with a 30 day share price return of 31.8% and...
NYSE:MSGE
NYSE:MSGEEntertainment

Does Oracle-Linked Data Breach Shift the Bull Case for Madison Square Garden Entertainment (MSGE)?

Madison Square Garden Entertainment Corp. recently disclosed that a data breach discovered on or about December 16, 2025 exposed personal information via a vulnerability in Oracle’s eBusiness Suite, prompting legal investigations by Edelson Lechtzin LLP on behalf of affected individuals. Beyond potential legal and remediation costs, this incident puts the company’s data security and operational controls under scrutiny at a time when it relies heavily on customer trust for its live...
NYSE:CHE
NYSE:CHEHealthcare

Chemed (CHE) Is Down 13.8% After Weaker 2025 Earnings And Soft 2026 Guidance Has The Bull Case Changed?

Chemed Corporation recently reported fourth-quarter 2025 results showing net income of US$76.75 million and full-year 2025 net income of US$265.24 million, both lower than the prior year, alongside 2026 adjusted earnings guidance of US$23.25–US$24.25 per diluted share. Despite ongoing share repurchases totaling US$2.62 billion since 2011, investors focused on pressure in VITAS and Roto-Rooter margins, including Medicare Cap constraints and water-restoration write-offs. We’ll now examine how...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

A Look At Tarsus Pharmaceuticals (TARS) Valuation After 2025 Results And New Shelf Registration

Tarsus Pharmaceuticals (TARS) recently reported full year 2025 results, with revenue of US$451.36 million and a net loss of US$66.42 million, and also filed a US$141.73 million shelf registration. See our latest analysis for Tarsus Pharmaceuticals. The latest earnings improvement and governance changes appear to sit behind a strong share price recovery, with a 30 day share price return of 17.01% and a one year total shareholder return of 76.78%. This is despite the year to date share price...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

The Bull Case For Copart (CPRT) Could Change Following Softer Q2 Revenue And Earnings Trends – Learn Why

In February 2026, Copart, Inc. reported that its second-quarter revenue slipped to US$1,121.67 million from US$1,163.32 million a year earlier, with net income easing to US$350.73 million and diluted earnings per share from continuing operations at US$0.36 versus US$0.40. An interesting contrast is that while quarterly revenue and profit dipped year over year, Copart’s net income for the first half of the fiscal year edged up slightly to US$754.45 million, with earnings per share essentially...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

A Look At QuidelOrtho (QDEL) Valuation After New Lifotronic Supply Agreement

QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States. See our latest analysis for QuidelOrtho. That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Assessing Erie Indemnity (ERIE) Valuation After 2025 Earnings And Planned CEO Transition

Earnings and leadership changes draw focus to Erie Indemnity (ERIE) Erie Indemnity (ERIE) has moved into the spotlight after releasing its full year 2025 results, showing revenue of US$4,067.26 million alongside lower net income and earnings per share compared with the prior year. See our latest analysis for Erie Indemnity. Investors have been weighing the full year 2025 results and the planned CEO transition against recent market performance, with the share price at US$269.44 and a 1 year...
NYSE:BDC
NYSE:BDCElectronic

Assessing Belden (BDC) Valuation After Strong Recent Share Price Momentum

Without a specific news headline driving attention, Belden (BDC) is drawing interest as investors look at its recent share performance, business profile, and current financial footprint in data infrastructure and industrial connectivity. See our latest analysis for Belden. Belden’s share price has pulled back 2.7% over the last day but still sits at US$143.30 after a strong 30 day share price return of 21.95% and a 1 year total shareholder return of 30.46%, which points to momentum that has...
NYSE:MCB
NYSE:MCBBanks

Metropolitan Bank (MCB) Is Down 6.2% After $178.5M Equity Raise To Fund Tech Push

Metropolitan Bank Holding Corp. recently completed a follow-on public offering of 2,100,000 common shares at US$85.00 each, raising about US$178.5 million to bolster capital and fund organic growth, technology investment, and general corporate purposes. The move meaningfully expands the bank’s equity base while supporting its post–Project Phoenix push into technology and AI-driven efficiency, reshaping how it finances future expansion. We’ll now examine how this sizeable equity raise, aimed...
NYSE:ABG
NYSE:ABGSpecialty Retail

Is Asbury’s US$500 Million Buyback And Dealership Sales Reshaping The Investment Case For ABG?

Asbury Automotive Group recently completed the sale of ten dealerships, generating about US$210 million in net proceeds and expanding its authorized share repurchase program to US$500 million, while also exiting a Chrysler Dodge Jeep Ram store that was acquired and rebranded as Indy CDJR by Matt Bowers. Together, these moves highlight Asbury’s ongoing portfolio reshaping and its preference to return capital to shareholders rather than reinvest all proceeds into owned dealership...
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

How Investors May Respond To Farmers National Banc (FMNB) Margin Pressures And Rising Credit Risk Concerns

Farmers National Banc recently drew heightened attention as a regional lender with a traditional community banking model centered on Ohio and nearby Midwest markets, where it is contending with margin pressure from higher deposit costs and slower loan repricing. What makes this situation especially important is the combination of rising credit risks in commercial real estate and small business portfolios with questions about how regulatory scrutiny and the interest‑rate backdrop could affect...
NYSE:CNS
NYSE:CNSCapital Markets

Should Cohen & Steers’ Higher Dividend Payout Shape How Investors View CNS’s Capital Priorities?

Cohen & Steers, Inc. recently declared a first-quarter 2026 cash dividend of US$0.67 per share, up from US$0.62 in the prior quarter, payable on March 19, 2026 to shareholders of record as of March 9, 2026. The 8.1% dividend increase highlights management’s willingness to return more cash to shareholders, which can be an important signal about the firm’s current capital position and confidence in its operations. We’ll now examine how this higher common-stock dividend, alongside the firm’s...
NYSE:ESRT
NYSE:ESRTOffice REITs

A Look At Empire State Realty Trust’s Valuation After Earnings, New Leases And Buybacks

Why Empire State Realty Trust is back on investors’ radar Empire State Realty Trust (ESRT) has moved back into focus after fourth quarter 2025 results showed higher quarterly revenue and net income year over year, alongside fresh leasing wins with major tenants. For the fourth quarter, ESRT reported sales of US$159.72 million and revenue of US$199.22 million, compared with US$155.13 million and US$197.6 million a year earlier. Net income came in at US$20.73 million versus US$12.22 million,...
NasdaqGM:FLGT
NasdaqGM:FLGTHealthcare

Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress

Fulgent Genetics (FLGT) is back on investors’ radar after its latest update, with 2025 earnings showing US$322.67 million in sales, a wider net loss, and fresh 2026 revenue guidance of about US$350 million. See our latest analysis for Fulgent Genetics. The share price reaction has been sharp, with a 1 day share price return of a 38.09% decline and a year to date share price return of a 40.09% decline, even though the 1 year total shareholder return is roughly flat. This suggests recent...
NYSE:NSA
NYSE:NSASpecialized REITs

Did NSA’s Strong Q4 Beat and 2026 EPS Guidance Just Shift National Storage Affiliates Trust's (NSA) Investment Narrative?

In February 2026, National Storage Affiliates Trust reported fourth-quarter 2025 results with revenue of US$187.03 million and net income of US$22.89 million, alongside full-year 2025 revenue of US$752.93 million and net income of US$73.78 million, and issued 2026 guidance that included diluted EPS of US$0.93 to US$1.03. Beyond the headline earnings beat, the company highlighted improving occupancy, sequential same-store revenue progress, and funds from operations above expectations, while...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Did Strong 2025 Results and Capital Returns Just Shift Safety Insurance Group's (SAFT) Investment Narrative?

Safety Insurance Group, Inc. reported past full-year 2025 results, with revenue of US$1,263.73 million and net income of US$99.26 million, alongside fourth-quarter net income of US$20.1 million on revenue of US$319.3 million. The company paired these stronger earnings with shareholder-focused actions, including repurchasing US$20 million of stock in the fourth quarter and approving a US$0.92 per-share quarterly dividend payable in March 2026. We’ll now examine how the combination of improved...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Assessing Goosehead Insurance (GSHD) Valuation After Earnings, 2026 Guidance, Expanded Buyback And Board Changes

Goosehead Insurance (GSHD) just packed earnings, fresh 2026 revenue guidance, an expanded buyback plan, and board changes into one announcement, giving investors several moving pieces to consider at once. See our latest analysis for Goosehead Insurance. The earnings release, fresh 2026 revenue guidance, larger buyback and board refresh came against a backdrop where Goosehead Insurance’s 7 day share price return of 18.29% contrasts with a 30 day share price return decline of 12.35% and a 1...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Why CoreWeave (CRWV) Is Down 12.4% After Hiking 2026 AI Capex And Posting Wider Losses

In late February 2026, CoreWeave reported fourth-quarter 2025 results showing sales rising to US$1.57 billion while net loss widened to US$452 million, alongside guidance for 2026 capital expenditures of US$30 billion to US$35 billion to expand AI data center capacity. Despite delivering full-year 2025 revenue of US$5.13 billion and expanding its contracted revenue backlog to about US$66.8 billion, the company’s heavier losses and aggressive spending plans raised fresh questions about its...
NYSE:DELL
NYSE:DELLTech

US Stock Market Today S&P 500 Futures Slide On Inflation And Geopolitical Jitters

The Morning Bull - US Market Morning Update Monday, Mar, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 futures down about 1.3% and Nasdaq futures off roughly 1.7%, as investors react to a mix of higher costs and geopolitical tension. Government bond yields in Italy, Germany and the UK are higher, which means borrowing is getting more expensive just as Middle East tensions keep energy prices and inflation worries alive. At the same time, factory scorecards such...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Is Down 60.6% After Forecasting 30% Q1 2026 Revenue Decline - What's Changed

In February 2026, Oddity Tech reported fourth-quarter 2025 sales of US$152.73 million and net income of US$5.88 million, alongside full-year 2025 sales of US$809.84 million and net income of US$110.75 million, while completing a US$47 million buyback of 1,250,000 shares previously announced in June 2024. At the same time, management guided to an approximately 30% year-over-year revenue decline for the first quarter of 2026 due to higher acquisition costs, highlighting a short-term...
NYSE:KNTK
NYSE:KNTKOil and Gas

How Stronger EPS And Kings Landing Progress At Kinetik Holdings (KNTK) Has Changed Its Investment Story

Kinetik Holdings Inc. recently reported fourth-quarter 2025 revenue of US$430.42 million and net income of US$416.70 million, with full-year 2025 revenue of US$1.76 billion and net income of US$525.93 million, marking a sharp jump in earnings per share from continuing operations versus 2024. Alongside these results, Kinetik highlighted progress on projects such as the Kings Landing sour-gas conversion and the Barilla Draw acquisition, while outlining a 2026 “rebuilding” mandate focused on...
NYSE:AAT
NYSE:AATREITs

How Insider Buying After Mixed Q4 Results At American Assets Trust (AAT) Has Changed Its Investment Story

In recent weeks, American Assets Trust's Executive Chairman Ernest S. Rady bought over US$212,000 of company stock across two transactions, lifting his indirect holdings to more than 8.1 million shares, shortly after the REIT posted mixed fourth-quarter 2025 results with earnings per share below forecasts but revenue ahead of expectations. These insider purchases come as commercial real estate sentiment weakens and interest rates remain elevated, suggesting leadership sees the portfolio’s...
NYSE:CSR
NYSE:CSRResidential REITs

A Look At Centerspace (CSR) Valuation After Earnings Update And Dividend Reaffirmation

Centerspace (CSR) drew fresh attention after releasing fourth quarter and full year 2025 results, issuing 2026 earnings guidance that points to a net loss, and reaffirming its quarterly dividend payout. See our latest analysis for Centerspace. The latest earnings update and guidance arrived after a stretch where the 1 year total shareholder return was roughly flat at 0.05%, even as the share price return year to date declined 6.08%. This hints that momentum has softened despite dividends...
NYSE:POR
NYSE:PORElectric Utilities

Is Portland General Electric’s 2025 Results and US$480 Million Equity Raise Altering The Investment Case For Portland General Electric (POR)?

In February 2026, Portland General Electric reported full-year 2025 revenue of US$3,576 million and net income of US$306 million, while also disclosing lower earnings per share than the prior year. On the same day, the company completed a roughly US$480 million follow-on common stock offering, signaling a major capital raise that meaningfully alters its equity base and funding mix. We’ll now examine how this substantial equity issuance may influence Portland General Electric’s investment...